logo
Plus   Neg
Share
Email

Abbott Sees Q4 Profit In Line With View; Narrows FY Profit View

Abbott Laboratories (ABT) said it expects earnings per share from continuing operations to be in the range of $0.59 to $0.61, and adjusted earnings per share from continuing operations of $0.94 to $0.96 for the fourth quarter. Analysts polled by Thomson Reuters expect the company to report earnings of $0.95 per share for the fourth-quarter. Analysts' estimates typically exclude special items.

Abbott narrowed its guidance for 2019 earnings per share from continuing operations to $2.06 to $2.08. Excluding specified items, adjusted earnings per share from continuing operations would be $3.23 to $3.25 for the full year 2019.

The company said in July that it expected earnings per share from continuing operations to be in the range of $2.06 to $2.12, adjusted earnings per share from continuing operations of $3.21 to $3.27. Analysts project annual earnings of $3.24 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT